# Bioequivalence Study of Valsatril Tablet Versus Entresto® Sacubitril/Valsartan 24/26 mg Tablet.

> **NCT07746908** · PHASE1 · COMPLETED · sponsor: **Center for Bioequivalence Studies and Clinical Research** · enrollment: 60 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Valsatril®
- **DRUG:** Entresto®

## Key facts

- **NCT ID:** NCT07746908
- **Lead sponsor:** Center for Bioequivalence Studies and Clinical Research
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-06
- **Primary completion:** 2025-07-18
- **Final completion:** 2025-07-18
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07746908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07746908, "Bioequivalence Study of Valsatril Tablet Versus Entresto® Sacubitril/Valsartan 24/26 mg Tablet.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07746908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*